SEC Info - Proto Labs Inc. - ‘8-K’ for 5/17/23

SEC Info℠

Home

Help

Please Sign In

Proto Labs Inc. – ‘8-K’ for 5/17/23

On: Thursday, 5/18/23, at 3:26pm ET · For: 5/17/23 · Accession #: 1437749-23-15104 · File #: 1-35435

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/18/23  Proto Labs Inc.                   8-K:5,9     5/17/23   12:351K                                   RDG Filings/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     81K 
 2: EX-10.1     Material Contract                                   HTML    114K 
 7: R1          Document And Entity Information                     HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- prlb20230517_8k_htm                 XML     13K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- prlb-20230517_def                XML     37K 
 5: EX-101.LAB  XBRL Labels -- prlb-20230517_lab                     XML     48K 
 6: EX-101.PRE  XBRL Presentations -- prlb-20230517_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- prlb-20230517                         XSD     14K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
12: ZIP         XBRL Zipped Folder -- 0001437749-23-015104-xbrl      Zip     44K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C:

i false i 0001443669 0001443669 2023-05-17 2023-05-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): i May 17, 2023

i Proto Labs, Inc.

(Exact name of registrant as specified in its charter)

i Minnesota		i 001-35435		i 41-1939628
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

i 5540 Pioneer Creek Drive i Maple Plain, i Minnesota		i 55359
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code:		( i 763) i 479-3680

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, Par Value $0.001 Per Share	i PRLB	i New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As reported below in Item 5.07, on May 17, 2023, the shareholders of Proto Labs, Inc. (the “Company”) approved an amendment to the Proto Labs, Inc. 2022 Long-Term Incentive Plan, which increased the number of shares available for issuance pursuant to awards under the plan by an additional 559,500 shares.

A description of the Proto Labs, Inc. 2022 Long-Term Incentive Plan, as amended, was included in the Company’s proxy statement for its annual meeting of shareholders filed with the Securities and Exchange Commission on April 4, 2023. A copy of the Proto Labs, Inc. 2022 Long-Term Incentive Plan, as amended, is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Shareholders on May 17, 2023 (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders elected all eight persons nominated by the Company’s board of directors to serve as directors until the next Annual Meeting of Shareholders or until their successors are elected and duly qualified. The Company’s shareholders also ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, approved an advisory vote on the compensation of the Company’s executive officers, approved the amendment to the Proto Labs, Inc. 2022 Long-Term Incentive Plan, and did not approve the shareholder proposal entitled Fair Elections. Set forth below are the final voting results for each of the proposals.

Proposal 1. Election of Directors.

Name	For		Against		Abstain		Broker Non-Votes

Robert Bodor		19,580,562		225,047		25,126		2,590,556
Archie C. Black		15,827,166		3,987,377		16,192		2,590,556
Sujeet Chand		17,615,018		2,201,653		14,064		2,590,556
Moonhie Chin		17,550,279		2,262,872		17,584		2,590,556
Rainer Gawlick		19,388,660		427,425		14,650		2,590,556
Stacy Greiner		19,610,484		203,527		16,724		2,590,556
Donald G. Krantz		19,448,117		366,069		16,549		2,590,556
Sven A. Wehrwein		18,897,052		920,247		13,436		2,590,556

Proposal 2. Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.

For	Against		Abstain		Broker Non-Votes

22,278,770		107,041		35,480		0

Proposal 3. Advisory approval of executive compensation.

For	Against		Abstain		Broker Non-Votes

16,986,784		2,797,389		46,562		2,590,556

Proposal 4. Approval of the amendment to the Proto Labs, Inc. 2022 Long-Term Incentive Plan.

For	Against		Abstain		Broker Non-Votes

19,402,862		406,619		21,254		2,590,556

Proposal 5. The shareholder proposal entitled Fair Elections failed by the following votes:

For	Against		Abstain		Broker Non-Votes

2,907,451		16,869,090		54,194		2,590,556

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

EXHIBIT INDEX

Exhibit No.		Description

10.1		Proto Labs, Inc. 2022 Long-Term Incentive Plan (As amended on May 17, 2023)

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PROTO LABS, INC.


Date: May 18, 2023	By:	/s/ *Robert Bodor*
		Robert Bodor
		President and Chief Executive Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	12/31/23
Filed on:	5/18/23
For Period end:	5/17/23
	4/4/23	DEF 14A, DEFA14A
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  Proto Labs Inc.                   10-K       12/31/23  100:10M                                    Workiva Inc Wde… FA01/FA
 8/04/23  Proto Labs Inc.                   S-8         8/04/23    4:144K                                   Workiva Inc Wde… FA01/FA
 8/04/23  Proto Labs Inc.                   10-Q        6/30/23   61:5.4M                                   Workiva Inc Wde… FA01/FA

↑Top

Filing Submission 0001437749-23-015104 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)